NANOG and hepatocellular carcinoma: In Nanog+ Huh7 HCC cells, the self-renewal and Nanog expression were decreased by the IGF1R inhibitors, such as picropodophyllin and AEW541, which suggested that the insulin growth factor (IGF) pathway might be downstream of Nanog [145].